Ultrathin and Smooth Pheomelanin-like Photoconductive Film.

This study introduces a facile method for the substrate-independent deposition of pheomelanin-like films, revealing unique and promising electrical characteristics. The conventional darkening of a dopamine solution at a basic pH was significantly delayed by the addition of l-cysteine, resulting in a distinctive temporal pattern: an initial quiescent period without apparent color change followed by an abrupt and explosive burst. Surprisingly, within the quiescent period, the deposition of ultrathin and smooth pheomelanin-like films was observed, in addition to rough and thick films formed after the burst. Regardless of thickness or texture, these films exhibited common chemical properties, including moisture-capturing capability and dark- and bright-state conductivities. Particularly noteworthy were consistent photocurrent responses under bias voltage across various pheomelanin-like films, which were not observed in polydopamine films, highlighting the influential role of l-cysteine addition. These findings present a novel avenue for the potential application of pheomelanin-like films in bioelectronics, emphasizing their distinct electrical characteristics and prompting further exploration into their intricate conductive mechanisms. The study contributes to advancing our understanding of melanin-based materials and their potential in diverse scientific and technological domains.

Are treatment effects consistent with hypothesized mechanisms of action proposed for postoperative delirium interventions? Reanalysis of systematic reviews.

Aim: Postoperative delirium (POD) is associated with increased morbidity and is poorly understood. The aim of this review was to identify putative mechanisms through re-analysis of randomized trials on treatment or prevention of POD. Materials & methods: A systematic review was performed to identify systematic reviews of treatments for POD. Constituent randomized controlled trials were identified, and interventions were grouped according to hypothesized mechanisms of action. Effects were meta-analyzed by hypothesized mechanism and timing of intervention. Results: A total of 116 randomized controlled trials described 47 individual interventions for POD, with nine mechanisms identified. The largest effects were observed for postoperative inflammation reduction, and preoperative reinforcement of sleep-wake cycle. Conclusion: This approach identifies treatments focused on mechanisms of action that may be front runners for future trials and interventions.

Prediction of Malignancy in Salivary Gland Tumors by a New Cytology Reporting System.

OBJECTIVES: The aim of this study was to analyze the risk of malignancy in salivary gland tumors on the basis of the Milan System for Reporting Salivary Gland Cytopathology. METHODS: A retrospective review was performed of the charts of patients with salivary gland tumors in whom the final diagnosis was confirmed by surgical excision. Preoperative fine needle aspiration results were categorized according to the Milan System for Reporting Salivary Gland Cytopathology: non-diagnostic (category I), nonneoplastic (category II), atypia of undetermined significance (category III), neoplasm (category IV), suspicious for malignancy (category V), and malignant (category VI). Fine needle aspiration and final diagnosis were compared, and the risk of malignancy and operative/oncological outcomes were analyzed. RESULTS: A total of 288 patients were enrolled in this study. Postoperative histopathologic salivary gland malignancies were found in 30 (10.4%) patients. Risk of malignancy was 7.1%, 0%, 48.0%, 4.8%, 88.7%, and 100% in categories I, II, III, IV, V, and VI, respectively. The most common malignant tumor in category III was salivary duct carcinoma (37.5%), followed by acinic cell carcinoma (25.0%), mucoepidermoid carcinoma (25.0%), and squamous cell carcinoma (12.5%). The 5-year survival rate of patients with malignant tumors showed no statistical difference between category III and category V/VI (P = .140). Risk of malignancy was 88.9% and 100% in category V and VI, respectively. CONCLUSIONS: A half of atypia of undetermined significance (category III) cases were malignant. Once diagnosed, the prognosis of malignant tumor in category III was similar with that in category V/VI.

Frustrated Lewis pairs with thermally activated delayed fluorescence properties: activation of formaldehyde.

Activation of formaldehyde (FA) by frustrated Lewis pairs (FLPs) that are comprised of bulky phosphines having a carbazolyl donor-triarylboryl acceptor unit and B(C6F5)3 led to the formation of FLP-FA adducts that exhibit a thermally activated delayed fluorescence.

Feasibility of Brachial Plexus Schwannoma Enucleation With Intraoperative Neuromonitoring.

OBJECTIVES: To evaluate the feasibility of brachial plexus schwannoma enucleation under intraoperative neuromonitoring. METHODS: Five patients who were treated for brachial plexus schwannoma under intraoperative neuromonitoring from 2008 to 2018 were included in this retrospective review. Neuromonitoring was performed with a 100-µV event threshold of the neuromonitoring system (NIM-2 or 3) at the deltoid, biceps brachii, triceps brachii, and brachioradialis muscles. Patient characteristics, tumor size and location, intraoperative neuromonitoring findings, and postoperative function were evaluated. RESULTS: The intraoperative neuromonitoring findings were in accordance with the preoperative assessment of the included nerve root. Three patients had no postoperative morbidity, one patient had temporary paresthesia of the forearm for 2 months, and one patient mild loss of grip strength for 1 month. CONCLUSION: Intraoperative neuromonitoring of the arm and forearm muscles during enucleation of brachial plexus schwannoma promoted confident and successful surgery with minimal postoperative morbidity.

Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers.

Colon cancer has been well studied using a variety of molecular techniques, including whole genome sequencing. However, genetic markers that could be used to predict lymph node (LN) involvement, which is the most important prognostic factor for colon cancer, have not been identified. In the present study, we compared LN(+) and LN(-) colon cancer patients using differential gene expression and network analysis. Colon cancer gene expression data were obtained from the Cancer Genome Atlas and divided into two groups, LN(+) and LN(-). Gene expression networks were constructed using LASSO (Least Absolute Shrinkage and Selection Operator) regression. We identified hub genes, such as APBB1, AHSA2, ZNF767, and JAK2, that were highly differentially expressed. Survival analysis using selected hub genes, such as AHSA2, CDK10, and CWC22, showed that their expression levels were significantly associated with the survival rate of colon cancer patients, which indicates their possible use as prognostic markers. In addition, protein-protein interaction network, GO enrichment, and KEGG pathway analysis were performed with selected hub genes from each group to investigate the regulatory relationships between hub genes and LN involvement in colon cancer; these analyses revealed differences between the LN(-) and LN(+) groups. Our network analysis may help narrow down the search for novel candidate genes for the treatment of colon cancer, in addition to improving our understanding of the biological processes underlying LN involvement. All R implementation codes are available at journal website as Supplementary Materials.

Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.

BACKGROUND: Long-term side effects after radiotherapy for organ preservation 'could deteriorate' the laryngeal function. This study intended to identify the incidence of severe late dysphagia following the multimodal treatment for stage III/IV laryngeal and hypopharyngeal cancer 'to evaluate the function of larynx'. METHODS: The medical records of patients successfully treated for laryngeal and hypopharyngeal cancer with a multimodal approach, including radiotherapy, were retrospectively analyzed. 'Functional larynx was defined as tolerable oral diet without severe late dysphagia or tracheostoma'. RESULTS: The study included 99 patients with a median follow-up period of 72 months. 'Tracheostomy during the follow-up period was required in only one patient due to aspiration pneumonia, and dysphagia is the main determinant for functional larynx'. The probability of maintaining functional larynx was 63% for 10 years, when the treatment was started with radiotherapy or concurrent chemoradiotherapy. In upfront surgery (operation first and adjuvant radiotherapy/concurrent chemoradiotherapy) group, 37% of patients required total laryngectomy as primary treatment and 43% of patients could maintain laryngeal function for 10 years. And severe late dysphagia in the latter group developed mainly after laryngeal preservation surgery. The patients aged ≥65 years showed significantly higher incidence of dysphagia. Severe late dysphagia was very rare in laryngeal cancer successfully cured with radiotherapy/concurrent chemoradiotherapy (1/25, 4%); however, it gradually increased over time in hypopharyngeal cancer patients showing a statistically significant difference from laryngeal cancer patients (P = 0.040). CONCLUSION: Severe late dysphagia occurred in 19.2% of patients treated for laryngeal and hypopharyngeal cancers, regardless of whether treatment started with radiotherapy/concurrent chemoradiotherapy or surgery.

Suppression of Wnt/ß-catenin signaling by EGF receptor is required for hair follicle development.

Mice that lack the epidermal growth factor receptor (EGFR) fail to develop a hair coat, but the mechanism responsible for this deficit is not completely understood. Here, we show that EGFR plays a critical role to attenuate wingless-type MMTV integration site family member (Wnt)/ß-catenin signaling during postnatal hair follicle development. Genetic ablation of EGFR in mice resulted in increased mitotic activity in matrix cells, apoptosis in hair follicles, and impaired differentiation of epithelial lineages that form hair. EGFR is activated in wild-type hair follicle stem cells marked with SOX9 or NFATc1 and is essential to restrain proliferation and support stem cell numbers and their quiescence. We observed elevated levels of Wnt4, 6, 7b, 10a, 10b, and 16 transcripts and hyperactivation of the ß-catenin pathway in EGFR knockout follicles. Using primary keratinocytes, we linked ligand-induced EGFR activation to suppression of nascent mRNA synthesis of Wnt genes. Overexpression of the Wnt antagonist sFRP1 in mice lacking EGFR demonstrated that elevated Wnts are a major cause for the hair follicle defects. Colocalization of transforming growth factor α and Wnts regulated by EGFR in stem cells and progeny indicates that EGFR autocrine loops control Wnts. Our findings define a novel mechanism that integrates EGFR and Wnt/ß-catenin pathways to coordinate the delicate balance between proliferation and differentiation during development.

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells.

Alveolar rhabdomyosarcoma (aRMS) is an aggressive subtype of the most common soft tissue cancer in children. A hallmark of aRMS tumors is incomplete myogenic differentiation despite expression of master myogenic regulators such as MyoD. We previously reported that histone methyltransferase KMT1A suppresses MyoD function to maintain an undifferentiated state in aRMS cells, and that loss of KMT1A is sufficient to induce differentiation and suppress malignant phenotypes in these cells. Here, we develop a chemical compound screening approach using MyoD-responsive luciferase reporter myoblast cells to identify compounds that alleviate suppression of MyoD-mediated differentiation by KMT1A. A screen of pharmacological compounds yielded the topoisomerase I (TOP1) poison camptothecin (CPT) as the strongest hit in our assay system. Furthermore, treatment of aRMS cells with clinically relevant CPT derivative irinotecan restores MyoD function, and myogenic differentiation in vitro and in a xenograft model. This differentiated phenotype was associated with downregulation of the KMT1A protein. Remarkably, loss of KMT1A in CPT-treated cells occurs independently of its well-known anti-TOP1 mechanism. We further demonstrate that CPT can directly inhibit KMT1A activity in vitro. Collectively, these findings uncover a novel function of CPT that downregulates KMT1A independently of CPT-mediated TOP1 inhibition and permits differentiation of aRMS cells.

Dual-Functional Electrocatalyst Derived from Iron-Porphyrin-Encapsulated Metal-Organic Frameworks.

Active, stable electrocatalysts based on non-precious metals for the oxygen reduction reaction (ORR) and hydrogen evolution reaction (HER) are critical for the development of cost-effective, efficient renewable energy technologies. Here, Fe/Fe3C-embedded nitrogen-doped carbon was fabricated via pyrolysis of iron-porphyrin-encapsulated mesoporous metal-organic frameworks [PCN-333 (Fe), where "PCN" stands for "porous coordination network"] at 700 °C. The various characterization techniques confirmed that Fe- and Fe3C-containing Fe-N-C material (FeP-P333-700) was successfully prepared by pyrolysis of porphyrin-encapsulated PCN-333 (Fe). FeP-P333-700 exhibited superior electrocatalytic performance for the ORR and HER owing to the synergistic effect of Fe/Fe3C and Fe-N-C active sites.

Morphology-Directed Selective Production of Ethylene or Ethane from CO2 on a Cu Mesopore Electrode.

The electrocatalytic conversion of CO2 to value-added hydrocarbons is receiving significant attention as a promising way to close the broken carbon-cycle. While most metal catalysts produce C1 species, such as carbon monoxide and formate, the production of various hydrocarbons and alcohols comprising more than two carbons has been achieved using copper (Cu)-based catalysts only. Methods for producing specific C2 reduction outcomes with high selectivity, however, are not available thus far. Herein, the morphological effect of a Cu mesopore electrode on the selective production of C2 products, ethylene or ethane, is presented. Cu mesopore electrodes with precisely controlled pore widths and depths were prepared by using a thermal deposition process on anodized aluminum oxide. With this simple synthesis method, we demonstrated that C2 chemical selectivity can be tuned by systematically altering the morphology. Supported by computational simulations, we proved that nanomorphology can change the local pH and, additionally, retention time of key intermediates by confining the chemicals inside the pores.

Through-space charge transfer and emission color tuning of di-o-carborane substituted benzene.

1,4-Di-(1-Ar-o-carboran-2-yl)benzene (Ar = 3,5-bis(trifluoromethyl)phenyl (1), phenyl (2), 4-n-butylphenyl (3), 4-N,N-dimethylaniline (4)) compounds that are electronically modulated at the C1-position of o-carborane with the electron-withdrawing or -donating aryl groups were prepared and characterized. The X-ray crystal structures of 1, 3, and 4 reveal that the two aryl groups on the C1-carborane carbon atoms are oppositely positioned, featuring overall C2-symmetry, and the C1-C2 bond length of carborane increases with the increasing order of electron-donating effect of an aryl group. UV-vis absorption spectra exhibit small low-energy absorption bands at around 275-300 nm for 1-3 while 4 shows a broad absorption tail at 350-400 nm. Although 1-4 show virtually no emission in solution, an intense aggregation-induced emission over the region ranging from 400-700 nm is observed in the solid state. Importantly, the emission wavelengths of 1-4 exhibit an apparent red-shift upon changing the aryl substituent from the CF3 to the NMe2 group (from 1 to 4). TD-DFT calculations suggest that the low-energy electronic transition is attributed to the intramolecular "through-space" charge transfer between the appended aryl group (HOMO) and the central phenylene ring (LUMO), and the greater change in the HOMO level by the substituent than that in the LUMO is responsible for the emission color tuning.

Biomedical and biochemical applications of self-assembled metallacycles and metallacages.

Metal ions and metal complexes with organic molecules are ubiquitous in nature. Bulk metal ions of Na, K, Mg, and Ca constitute as much as 1% of human body weight. The remaining trace ions, most commonly of Fe, Ni, Cu, Mn, Zn, Co, Mo, and V, make up ∼0.01% by weight, but their importance in biological processes cannot be overstated. Although nature is limited to the use of bioavailable metal ions, many rarer transition metals can elicit novel biological responses when they interact with biomolecules. For this reason, metal-biomolecule complexes are of interest in medicinal applications. A well-known example is cisplatin, which contains Pt, rare in nature, but highly effective in this context as an anticancer drug in the form of cis-Pt(NH3)2Cl2 and analogous Pt(II) complexes. This and other examples have led to strong interest in discovering new metalloanticancer drugs. In this Account, we describe recent developments in this area, particularly, using coordination-driven self-assembly to form tunable supramolecular coordination complexes (SCCs) with biomedical applications. Coordination-driven self-assembly describes the spontaneous formation of metal-ligand bonds in solution, transforming molecular building blocks into single, 2D metallacycles, or 3D metallacages depending on the directionality of the precursors used. Such SCCs have well-defined internal cavities and simple pre- or post-self-assembly functionalizations. They are highly tunable both spatially and electronically. Metal ions are necessary structural elements for the directional bonding approach, which can be exploited to provide biological activity to an SCC, particularly for Pt- and Ru-based structures. Since these two metals are not only among the most commonly used for coordination-driven self-assembly but are also the basis for a number of small molecule anticancer agents, researchers have evaluated a growing number of SCCs for their antitumor properties. The biological application of SCCs is still an emergent field of study, but the examples discussed in this Account confirm that supramolecular scaffolds have relevance to a wide variety of biochemical and biomedical targets. SCCs can serve as anticancer agents, act as selective sensors for biologically important analytes, or interact with DNA and proteins. The myriad of possible SCCs and their almost limitless modularity and tunability without significant synthetic penalty suggests that the biological applications of such species will continue along this already promising path.

Enhanced secretion of biologically active, non-glycosylated VEGF from Saccharomyces cerevisiae.

Vascular endothelial growth factor (VEGF) mediates angiogenesis, which plays a critical role in the development and differentiation of the vascular system. VEGF is a homodimeric glycoprotein that contains one N-glycosylation site. In this study, we evaluated Saccharomyces cerevisiae expression systems producing glycosylated and non-glycosylated splice variants of human VEGF, VEGF121, and VEGF165. The pre region of the mating factor α1 (MFα1) signal sequence was found to perform better than the entire MFα1 prepro signal sequence in secreting glycosylated VEGF. Secretion of non-glycosylated VEGF165 was completely blocked, indicating the importance of glycosylation in VEGF165 secretion. Interestingly, non-glycosylated VEGF165 was secreted when guided by the MFα1 prepro signal sequence, albeit to a lesser degree, compared to glycosylated VEGF165. N-glycosylation in the pro region was required for the prepro sequence to promote VEGF secretion. Furthermore, substitution of asparagine at the VEGF glycosylation site with lysine or glutamic acid increased secretion of non-glycosylated VEGF, a finding not previously reported. Our findings suggest that S. cerevisiae could be a suitable host for secreting biologically active, non-glycosylated VEGF for clinical use.

Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.

While many cancers show a sex bias, the genetic basis and molecular mechanisms underlying sex bias are not always clear. Astrocytoma and glioblastoma show male predominance in humans. We have shown previously that glial tumors forming in the Nf1-/+; Trp53-/+cis (NPcis) mouse model also show a sex bias in some genetic contexts. Using cross-species comparisons we have identified candidate male-specific modifiers of astrocytoma/glioblastoma. Linkage analysis of B6X(B6X129)-NPcis mice identifies a modifier of astrocytoma resistance specific to males, named Arlm1, on distal mouse Chr 12. Arlm1 is syntenic to human Chr 7p15, 7p21, 7q36, and 14q32 regions that are altered in human glioblastoma. A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene. Identification of male-specific modifier genes will lead to a better understanding of the molecular basis of male predominance in astrocytoma and glioblastoma.

Roll-to-roll anodization and etching of aluminum foils for high-throughput surface nanotexturing.

A high-throughput process for nanotexturing of hard and soft surfaces based on the roll-to-roll anodization and etching of low-cost aluminum foils is presented. The process enables the precise control of surface topography, feature size, and shape over large areas thereby presenting a highly versatile platform for fabricating substrates with user-defined, functional performance. Specifically, the optical and surface wetting properties of the foil substrates were systematically characterized and tuned through the modulation of the surface texture. In addition, textured aluminum foils with pore and bowl surface features were used as zeptoliter reaction vessels for the well-controlled synthesis of inorganic, organic, and plasmonic nanomaterials, demonstrating yet another powerful potential use of the presented approach.

Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.

Alveolar rhabdomyosarcoma (ARMS) is an aggressive pediatric muscle cancer, which arrested during the process of skeletal muscle differentiation. In muscle myoblast cells, ectopic expression of the histone H3 lysine 9 (H3K9) methytransferase KMT1A blocks differentiation by repressing a myogenic gene expression program. In this study, we tested the hypothesis that activation of a KMT1A-mediated program of transcriptional repression prevents ARMS cells from differentiating. We investigated whether KMT1A represses the expression of differentiation-associated genes in ARMS cells, thereby blocking muscle differentiation. Our results show that expression of KMT1A is induced in human ARMS cancer cell lines when cultured under differentiation-permissible conditions. shRNA-mediated knockdown of KMT1A decreased anchorage dependent and independent cell proliferation and tumor xenograft growth, increased expression of differentiation-associated genes, and promoted the appearance of a terminally differentiated-like phenotype. Finally, shRNA-directed KMT1A knockdown restored the impaired transcriptional activity of the myogenic regulator MyoD. Together, our results suggested that high levels of KMT1A in ARMS cells under differentiation conditions impairs MyoD function, thereby arresting myogenic differentiation in these tumor cells. Thus, targeting KMT1A may be a novel strategy for the treatment of this disease.

Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment.

PURPOSES: To avoid unwanted adverse effects of higher doses of single treatment of stem cells and gene therapy and increase the therapeutic efficacies, we hypothesized the combined therapy with stem cells and gene therapy. This study assessed the neuroprotective effects of combined gene therapy and stem cell treatment under ischemic hypoxia conditions using hypoxia-inducible vascular endothelial growth factor (VEGF) and bone marrow-derived mesenchymal stem cells (BMSC). METHODS: Experimental groups included the control which was N2A cells transfected with empty vectors, the transfection only group which was N2A cells treated with pEpo-SV-VEGF alone, the BMSC only group which was N2A cells transfected with empty vectors and cocultured with BMSCs, and the combined treatment group which was N2A cells treated with pEpo-SV-VEGF and cocultured with BMSCs. Each group was transfected for 4 h and cultured at 37 degrees C and 5% CO2 for 24 h. Each group was then cultivated under hypoxic conditions (1% O2) for 12 h. Neuroprotective effects were assessed by reverse transcription polymerase chain reaction, annexin V, and cytotoxicity assay. RESULTS: Neurons exposed to hypoxic conditions exhibited neuronal apoptosis. Compared to single treatments, the combined hypoxia-inducible VEGF and BMSC treatment demonstrated a significant increase in VEGF expression and decreased neuronal apoptosis. CONCLUSIONS: These results suggest that combined pEpo-SV-VEGF and BMSC treatment is effective in protecting neurons against hypoxic ischemic injury.

Synthesis and properties of salen-aluminum complexes as a novel class of color-tunable luminophores.

Showing their true colors? Full emission color tuning in the visible region can be achieved with salen-aluminum complexes that are electronically modulated at C5 of the phenoxide ring in the salen moiety. Emission spectra for various substituents R(5) are shown (EWG: electron-withdrawing group, EDG: electron-donating group).A series of salen-aluminum complexes, [{(R(5))(2)-salen(3-tBu)(2)}Al(OC(6)H(4)-p-C(6)H(5))] (salen=N,N'-bis(salicylidene)ethylenediamine; R(5)=H (1), tBu (2), Br (3), Ph (4), OMe (5), NMe(2) (6)) and [{5,5'-(NMe(3))(2)-salen(3-tBu)(2)}Al(OC(6)H(4)-p-C(6)H(5))][OTf](2) (7; OTf=CF(3)SO(3)) that are electronically modulated directly at C5 of the phenoxide ring in the salen moiety has been prepared. The crystal structures of 1, 4, 6, and 7 determined by X-ray diffraction reveal distorted square-pyramidal geometries around the Al atoms. Complexes 1-7 are all air-stable in both the solid and solution states and have high thermal stability (decomp 313-338 degrees C). Differential scanning calorimetric analyses show that they can form amorphous glasses with glass transition temperatures of 95-132 degrees C depending on the C5 substituent. UV/Vis absorption spectra of the complexes exhibit major bands at lambda=338-413 nm assignable to salen-centered pi-pi* transitions with a gradual red shift of the absorption maximum wavelengths as the substituent is varied from an electron-withdrawing (NMe(3)) to an electron-donating group (NMe(2)). The maxima in the emission spectra of 1-7 occur over the entire visible region, ranging from lambda=438 nm for 7 to lambda=599 nm for 6, with high fluorescence quantum efficiencies of up to Phi=0.40 for 4 in solution. DFT calculations suggest that the low-energy electronic transitions in 1-7 are characterized by HOMO(-i)-LUMO(+1) (i=1 for 1-6 or i=4 for 7) transitions localized on the salen moiety, with much involvement of the C5 position in the HOMO(-i). Thus, the electronic alteration at the C5 position of the phenoxide ring, which mainly affects the HOMO(-i) energy levels of salen-Al luminophores, is responsible for the observed emission color-tuning properties over the entire visible region.

Elaboration of rac-like active species from Lewis base functionalized unbridged zirconocenes for isospecific propylene polymerization.

A series of ortho or meta Lewis base functionalized unbridged zirconocenes, [{1-(E(n)-Ph)-3,4-Me(2)C(5)H(2)}(2)ZrCl(2)] (E = NMe(2), OMe; n = 1, 2), and a half-functionalized zirconocene, [{1-(p-Me(2)NC(6)H(4))-3,4-Me(2)C(5)H(2)}{1-(p-tolyl)-3,4-Me(2)C(5)H(2)}ZrCl(2)], were prepared. The crystal structures of these compounds determined by X-ray diffraction revealed the presence of only C(2)-symmetric rac-like isomers in the asymmetric units. In combination with methylaluminoxane (MAO) cocatalyst, the meta-functionalized complexes afforded mixtures of polymers that exhibit multimelting transition temperatures and broad molecular-weight distributions (MWDs) in propylene polymerization at atmospheric monomer pressure, whereas the ortho-functionalized complexes did not give rise to polymerization. Stepwise solvent extraction of the polymer mixtures showed that the polymers consist of amorphous, moderately isotactic, and highly isotactic portions, the weight ratio of which is dependent on the reaction temperature. (13)C NMR spectral analysis indicated that the [mmmm] methyl pentad value of the isotactic portion reached around 90%. Among the meta-functionalized zirconocenes, the di-OMe-substituted one afforded the largest amount of the isotactic portion at all temperatures, and the portion comprised 82 wt % of the crude polymer obtained at 25 degrees C. In contrast, propylene polymerization with the half-functionalized unbridged zirconocene resulted in the formation of nearly atactic polypropylene with a narrow MWD of around 2. These results corroborate the proposition that the rigid rac-like cation-anion ion pair of type [rac-L(2)ZrP](+)[Me-MAO](-) generated in situ, through Lewis acid-base interactions between the functional groups and [Me-MAO](-), is responsible for the isospecific propylene polymerization with the given class of functionalized unbridged zirconocenes and further indicate that the formation of such ion pairs can be favored by difunctionalization at the meta position of the phenyl ring with OMe groups.